Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2020

Feb 12, 2021

BUY
$4.79 - $8.39 $824,651 - $1.44 Million
172,161 Added 9900.0%
173,900 $1.46 Million
Q2 2020

Aug 14, 2020

SELL
$4.79 - $8.39 $805,491 - $1.41 Million
-168,161 Reduced 98.98%
1,739 $704,000
Q1 2020

Feb 12, 2021

BUY
$3.44 - $7.21 $578,611 - $1.21 Million
168,201 Added 9900.0%
169,900 $890,000
Q1 2020

May 15, 2020

BUY
$3.44 - $7.21 $5,844 - $12,249
1,699 New
1,699 $302,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $2.08B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.